ELV - CIK 0001156039
Elevance Health, Inc. has filed 1,000 documents with the SEC between 2013 and 2026. The most frequent type is insider trade (507 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2026-05-20 | 2026-05-19 |
| Insider sale notice | 144 | 2026-05-19 | - |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 | 2026-05-13 |
| SCHEDULE 13G | - | 2026-04-29 | - |
| Quarterly report | 10-Q | 2026-04-22 | 2026-03-31 |
| Major company event | 8-K | 2026-04-22 | 2026-04-22 |
| Shareholder proxy notice | PX14A6G | 2026-04-07 | - |
| Proxy materials | DEFA14A | 2026-03-27 | - |
| Proxy statement | DEF 14A | 2026-03-27 | 2026-05-13 |
| SCHEDULE 13G/A | - | 2026-03-26 | - |
| Insider trade | 4 | 2026-03-23 | 2026-03-12 |
| Major company event | 8-K | 2026-03-10 | 2026-03-10 |
| Insider trade | 4 | 2026-03-09 | 2026-03-06 |
| Insider sale notice | 144 | 2026-03-06 | - |
| Insider trade | 4 | 2026-03-06 | 2026-03-05 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Major company event | 8-K | 2026-03-02 | 2026-03-02 |
| Major company event | 8-K | 2026-02-26 | 2026-02-26 |
| Annual report | 10-K | 2026-02-06 | 2025-12-31 |
| Insider trade | 4 | 2026-02-03 | 2026-02-02 |
| Insider trade | 4 | 2026-02-03 | 2026-02-02 |
| Major company event | 8-K | 2026-01-28 | 2026-01-28 |
| New insider ownership | 3 | 2026-01-14 | 2026-01-12 |
| Major company event | 8-K | 2025-12-10 | 2025-12-10 |
| 3/A | - | 2025-11-21 | 2025-08-11 |
| Major company event | 8-K | 2025-11-10 | 2025-11-10 |
| Major company event | 8-K | 2025-10-21 | 2025-10-21 |
| Quarterly report | 10-Q | 2025-10-21 | 2025-09-30 |
| Insider trade | 4 | 2025-10-03 | 2025-10-02 |
| Major company event | 8-K | 2025-09-15 | 2025-09-08 |
| 424B3 | - | 2025-09-09 | - |
| Free writing prospectus | FWP | 2025-09-08 | - |